cyc 202 has been researched along with rifampin in 4 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | cyc 202 (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ikari, A; Kurosawa, M; Miwa, M; Sugatani, J; Uchida, T; Yamaguchi, M; Yamazaki, Y | 1 |
| Hattori, Y; Ikari, A; Noguchi, Y; Sugatani, J; Yamaguchi, M; Yamazaki, Y | 1 |
4 other study(ies) available for cyc 202 and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Regulation of pregnane X receptor (PXR) function and UGT1A1 gene expression by posttranslational modification of PXR protein.
Topics: Acetylation; Basic Helix-Loop-Helix Transcription Factors; Constitutive Androstane Receptor; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Enzymologic; Glucuronosyltransferase; Heat-Shock Proteins; Hep G2 Cells; HSP40 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Immunoprecipitation; Molecular Chaperones; Mutation; Nuclear Receptor Coactivator 2; Phosphorylation; Pregnane X Receptor; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Transport; Purines; Receptors, Aryl Hydrocarbon; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Retinoid X Receptors; Rifampin; RNA Interference; Roscovitine; Serine; Time Factors; Transcriptional Activation; Transfection | 2012 |
Threonine-290 regulates nuclear translocation of the human pregnane X receptor through its phosphorylation/dephosphorylation by Ca2+/calmodulin-dependent protein kinase II and protein phosphatase 1.
Topics: Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line; Cell Nucleus; Gene Expression Regulation, Enzymologic; Glucuronosyltransferase; HSP90 Heat-Shock Proteins; Humans; Liver; Mice; Mutation; Okadaic Acid; Phosphorylation; Pregnane X Receptor; Protein Phosphatase 1; Protein Transport; Purines; Receptors, Steroid; Rifampin; RNA, Small Interfering; Roscovitine; Sulfonamides; Threonine | 2014 |